Talk:Lung cancer

Active discussions
Lung cancer is a featured article; it (or a previous version of it) has been identified as one of the best articles produced by the Wikipedia community. Even so, if you can update or improve it, please do so.
This article appeared on Wikipedia's Main Page as Today's featured article on November 18, 2007.
Article milestones
DateProcessResult
June 22, 2007Good article nomineeListed
August 10, 2007Peer reviewReviewed
September 29, 2007Featured article candidatePromoted
Current status: Featured article

Suggestion to submit to the WikiJournal of MedicineEdit

Hello! This is a top importance medical article and is already rated as being really high quality. Could it be further improved with the help of feedback from academic experts? To find out, submit it to the WikiJournal of Medicine.

Reasons for submittingEdit

  • Get feedback from external experts, and recommendations from our academic editors.
  • Get recognition for your work, in the form of a citable publication (all page contributors will also be clearly acknowledged).

What we needEdit

  • An editor who already made substantial contributions to this article, and who is willing follow it through the editorial process, from initial submission to reacting to recommendations. This involves temporarily working on a separate version of this article at Wikiversity.
  • No fees involved: WikiJournals are both open access and fee-free.

How to submitEdit

Why this articleEdit

We are putting this notice on a few of the highest-importance medical articles in Wikipedia. This article was chosen by one of our editors who is motivated to follow it through the process, and thinks it has good chances of being eventually accepted for publication. (Examples: an accepted article, a declined article.) Of course, spontaneous submissions are also welcome!

T.Shafee(Evo&Evo)talk 12:04, 6 July 2019 (UTC)

DiscussionEdit

User:Axl, I'm guessing you would like to preserve your anonymity. T.Shafee(Evo&Evo), I did have a general question for the WikiJournal of Medicine. If Axl wants to remain anonymous and this article was published would there be a way to acknowledge that Axl (assuming they're OK with being acknowledged by their Wikipedia user name in an academic publication) is the first author? I know they've put a ton of work into this article. Or would there be a mention that the person whose real name is the "first author" isn't the actual first author? Could et al as the abbreviated form of anonymous editors be designated the first author? Are pen names allowed? I was curious about these kinds of scenarios. Thanks. Biosthmors (talk) 14:47, 9 February 2020 (UTC)
I don't particularly feel any need to preserve my anonymity. I have previously rebutted a critique of this article by Hasty, using my real name. I am certainly happy to accept the scrutiny of the WikiJournal of Medicine.
Perhaps most importantly, it has been a few years since I fully reviewed all of the sources. I suspect that some parts of the article are outdated. Axl ¤ [Talk] 17:17, 9 February 2020 (UTC)
Two statements about the article that include my real name. Axl ¤ [Talk] 18:02, 9 February 2020 (UTC)
@Biosthmors and Axl: Hi both. Notwithstanding Axl's previous comment on being comfortable with open identity, I through I'd also add a note here on anonymity/pseudonymity generally. We've so far had to avoid anonymous listed authors, since one of the ICMJE Authorship criteria has traditionally been interpreted as indicating that authors must be identifiable (name, affiliation, contactable):
"Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved."
However, other journals have published items by anon/pseudonymous authors in the past (example). I've been looking into making an ICMJE compliant pocess, but have been shocked that there's currently no published documentation on best practices. What that means is that in the short term, although we can't include an anon/psudonymous authors in the author list, we could include one or more as named 'contributor(s)' at the end of the authors list (same way that we include the et al hyperlink to a full contributor list). Considering that journals are used to dealing with anonymous peer reviewers, it should be possible to eventuially put systems in place. T.Shafee(Evo&Evo)talk 06:10, 10 February 2020 (UTC)
Thank you Axl and T.Shafee(Evo&Evo) for your replies. Axl, FYI, I'm updating deep vein thrombosis right now with the end goal of submitting it to the journal. Maybe 2020 is the year to to get both of these articles published formally. Biosthmors (talk) 14:46, 11 February 2020 (UTC)

Immunotherapy: New compoundsEdit

Should the section mention Nivolumab and Ipilimumab? Opdivo (nivolumab) and Yervoy (ipilimumab) are labeled in both USA and EU at this point, combination therapy just being filed [1] — Preceding unsigned comment added by Sprevrha (talkcontribs) 21:45, 6 May 2020 (UTC)

Return to "Lung cancer" page.